Cargando…
NOX4 inhibition promotes the remodeling of dystrophic muscle
The muscular dystrophies (MDs) are genetic muscle diseases that result in progressive muscle degeneration followed by the fibrotic replacement of affected muscles as regenerative processes fail. Therapeutics that specifically address the fibrosis and failed regeneration associated with MDs represent...
Autor principal: | Hammers, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714779/ https://www.ncbi.nlm.nih.gov/pubmed/36278481 http://dx.doi.org/10.1172/jci.insight.158316 |
Ejemplares similares
-
Nox4 promotes endothelial differentiation through chromatin remodeling
por: Hahner, F., et al.
Publicado: (2022) -
Nox2 and Nox4 mediate tumour necrosis factor-α-induced ventricular remodelling in mice
por: Moe, K T, et al.
Publicado: (2011) -
Immunoproteasome Inhibition Ameliorates Aged Dystrophic Mouse Muscle Environment
por: Tripodi, Luana, et al.
Publicado: (2022) -
Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity
por: Hardee, Justin P., et al.
Publicado: (2020) -
Nox2 in regulatory T cells promotes angiotensin II–induced cardiovascular remodeling
por: Emmerson, Amber, et al.
Publicado: (2018)